Skip to main content
Clinical Trials/DRKS00012898
DRKS00012898
Recruiting
Not Applicable

Impact of transcatheter aortic valve implantation on platelet function and turnover in patients with valvular aortic stenosis

niversitaets-Herzzentrum Freiburg Bad Krozingen Klinik für Kardiologie und Angiologie II0 sites550 target enrollmentAugust 28, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I35.0
Sponsor
niversitaets-Herzzentrum Freiburg Bad Krozingen Klinik für Kardiologie und Angiologie II
Enrollment
550
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 28, 2017
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitaets-Herzzentrum Freiburg Bad Krozingen Klinik für Kardiologie und Angiologie II

Eligibility Criteria

Inclusion Criteria

  • Indication for interventional aortic valve replacement (CoreValve®/Evolut®R or Edwards Sapien3®), age \= 60 years, written informed consent

Exclusion Criteria

  • Known severe disorder of the coagulation system, known hematologic diseases, severe hepatopathy, hemodialysis, contraindication for treatment with TAVI, peri\- or postinterventional transfusions of fresh frozen plasma (FFP), platelets or coagulation factors

Outcomes

Primary Outcomes

Not specified

Similar Trials